Cargando…
WHO essential medicines for reproductive health
Autores principales: | Gill, Roopan, Ganatra, Bela, Althabe, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6936467/ https://www.ncbi.nlm.nih.gov/pubmed/31908878 http://dx.doi.org/10.1136/bmjgh-2019-002150 |
Ejemplares similares
-
WHO recommendations on uterotonics for postpartum haemorrhage prevention: what works, and which one?
por: Vogel, Joshua P, et al.
Publicado: (2019) -
NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020) -
In-country availability of medical abortion medicines: a description of the framework and methodology of the WHO landscape assessments
por: Rehnström Loi, Ulrika, et al.
Publicado: (2023) -
Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016) -
WHO Multi-Country Survey on Abortion-related Morbidity and Mortality in Health Facilities: study protocol
por: Kim, Caron R, et al.
Publicado: (2016)